RESUMO
Two cases of psychosis after upper respiratory infection were reported. New mental illness among children was substantiated after analyzing the cause of psychosis during the past 10 years of practice. It is confirmed that there is an association between psychosis and upper respiratory infection.
Assuntos
Transtornos Psicóticos/etiologia , Infecções Respiratórias/complicações , Adolescente , Criança , Humanos , Masculino , Transtornos Psicóticos/diagnósticoRESUMO
Headaches and nausea are the 2 most common adverse effects of electroconvulsive therapy (ECT). These adverse effects have been frequently reported in the postictal period and make it difficult for the patient to continue with the following ECTs. Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors. This mechanism has been hypothesized to be the underlying therapeutic effects for depression and anxiety. In addition, mirtazapine possesses antagonistic effects on the postsynaptic serotonin 5-HT2 and 5-HT3 receptors. The pharmacological actions are hypothesized to be related to its treatment effects of headaches and nausea. Here, we report a case series of patients developing post-ECT headaches and nausea, and the concomitant administration of mirtazapine successfully relieved the ECT-associated adverse effects. This case series suggest that mirtazapine may be an optional treatment for ECT-induced headaches and nausea.
Assuntos
Antidepressivos Tricíclicos/uso terapêutico , Eletroconvulsoterapia/efeitos adversos , Cefaleia/tratamento farmacológico , Transtornos Mentais/terapia , Mianserina/análogos & derivados , Náusea/tratamento farmacológico , Adulto , Transtorno Depressivo Maior/terapia , Feminino , Cefaleia/etiologia , Humanos , Mianserina/uso terapêutico , Pessoa de Meia-Idade , Mirtazapina , Náusea/etiologia , Transtornos Psicóticos/terapia , Estudos Retrospectivos , Esquizofrenia/terapiaRESUMO
Symptomatic bradycardia following a single low dose of oral trazodone is rare. Herein, we report the case of a patient with major depressive disorder who developed and was able to resolve symptomatic bradycardia following administration of a single low dose of trazodone 50mg, and then discontinuation. This is the first case report of symptomatic bradycardia which might be attributed to a single lowest dose of trazodone in the world.
